|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||132.90 - 134.79|
|52 Week Range||109.32 - 137.08|
|PE Ratio (TTM)||22.64|
|Dividend & Yield||3.36 (2.52%)|
|1y Target Est||N/A|
A massive California verdict in a lawsuit alleging Johnson & Johnson's (JNJ.N) talc-based products cause cancer has opened a new front in the litigation, upending the company's hopes that the cases were only gaining traction in Missouri, legal experts said. The $417 million award by California jury to a California resident suggested so-called forum-shopping, in which parties seek to file cases in whichever jurisdictions seem most favorable, may not be the main problem facing J&J as it wrestles with some 4,800 outstanding talc lawsuits. J&J, which denies any link between talc and cancer, said in a statement it would appeal Monday's verdict but declined further comment.
Iran's new telecommunications minister says Twitter is ready to talk about unblocking access to the microblogging site
A jury just ordered J&J to pay a woman with ovarian cancer $417 million.